Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P14
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-132.03M | +2.6% |
| 2024 | $-135.50M | -58.7% |
| 2023 | $-85.39M | +30.5% |
| 2022 | $-122.92M | -41.3% |
| 2021 | $-87.01M | -129.3% |
| 2020 | $296.71M | +2415.1% |
| 2019 | $-12.82M | -61.8% |
| 2018 | $-7.92M | - |